The scientific update shows how far this company had come. It speaks volumes that in a matter of months they will be in phase 1 clinical trials. All that means is 8-10 people will be the subject of the test. Phase 2 is 20 or more people. Before the much more detailed phase 3 can start. Once they are approved by health Canada to commence trials you will see the interest in this company explode. With 0 debt they are a pharmaceutical companies dream. We are on the cusp of one of those stocks where you will say "wow I could have owned so much at 6 cents. Good luck all.